Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortIV antiviral for CMV infection in transplant and HIV patients.Oral prodrug of ganciclovir for CMV treatment and prevention.
Body systemAntiviralsAntivirals
Drug classNucleoside analogues (herpes)Nucleoside analogues (herpes)
SupplyPrescription onlyPrescription only
Main usesCMV retinitis, CMV disease in transplant recipients, CMV prevention after transplantCMV prevention after transplant, CMV retinitis, Congenital CMV (specialist)
How it worksStops cytomegalovirus from multiplying.Stops cytomegalovirus from multiplying.
Starts workingDaysDays
Half-life2–4 hoursAbout 4 hours
Typical adult dose5 mg/kg IV every 12 hours for induction, then once daily for maintenance.900 mg twice a day for induction, then 900 mg once a day for maintenance or prevention.
FormsIV infusionTablet, Oral solution
Common side effectsFever, Low blood counts, Nausea, DiarrhoeaDiarrhoea, Nausea, Low white cells, Headache
Serious side effectsSevere neutropenia and anaemia, Low platelets, Seizures, Birth defectsSevere neutropenia and anaemia, Low platelets, Seizures, Birth defects
Don't take ifVery low neutrophil or platelet counts; Pregnancy; Allergy to aciclovir (cross-reactivity)Very low blood counts; Pregnancy; Breastfeeding
AlcoholUsually no problem in moderation. Not directly relevant.Best to limit. Alcohol may worsen nausea.
PregnancyUsually avoidedHarmful to the baby; avoid unless life-threatening.Usually avoidedHarmful to the baby.
BreastfeedingUsually avoidedAvoid.Usually avoidedAvoid.
In use since——
Brand namesUnited States: CytoveneUnited Kingdom: CymeveneIndia: Cytovene, Ganciclovir (generic)United States: ValcyteUnited Kingdom: ValcyteIndia: Valcyte, Valcyt
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule HUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H
ATC codeJ05AB06J05AB14

Taken together

  • ModerateGanciclovir + Valganciclovir: Added bone marrow suppression

    Both can lower white cells, red cells or platelets; together the risk of infection and bleeding rises.

Open in the interaction checker